Trial NCT03002103

View at ClinicalTrials.gov 
Org. Study IDs: CT4005

Last trial update was posted on 2023-04-26

MeSH Interventions

Gemcitabine Paclitaxel

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Triple-Negative Breast Cancer

Stopping Reasons

study design reconsideration

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID